Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Molecular Therapy: Oncology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all
“Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors.” Molecular Therapy: Oncology.
@article{article101012,
title = {Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all}
}